home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Nanotechnology: Innovation, Opportunity and Commercialization

  May 25, 2017  
CfPA-The Center for Professional Advancement, Online Live
July 27, 2017 at 11:00 a.m.–12:30 p.m. (ET)

Who Should Attend?
This training is intended for professionals involved with biomedicine, law, medicine, pharma, biotech, drug development, regulatory science, intellectual property law, future studies or governmental affairs. 

It will benefit academic researchers and scientists, professors, post-doctoral fellows, graduate and undergraduate students, physicians, engineers, patent lawyers, regulatory personnel, pharmaceutical and biotechnology personnel, technology transfer officers, business managers, venture capitalists and policy makers. 

This course will be of interest to federal agencies such as the NIH, FDA, NASA, SBA, NSF, NIST, NCI, USDOC, US Army and the Patent Office.

Course Description
Nanotechnology has permeated virtually every sector of the global economy and Nanotech is driven by collaborative research, patenting, commercialization, business development and technology transfer within diverse areas such as biomedical sciences, chemical engineering, biotechnology, physical sciences, and information technology. This 90-minute accredited training discusses nanotechnology in the context of business activities, nanoproduct development and commercialization. It examines the entire “product life cycle,” from the creation of nanomedical products to their final market introduction. While focusing on critical issues relevant to nanoproduct development and translational activities, it tackles topics such as regulatory science, patent law, FDA law, personalized medicine, risk analysis, toxicology, nano-characterization and commercialization.
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
Dr. Raj Bawa, President, Bawa Biotech LLC and Adjunct Professor, Rensselaer Polytechnic Institute

Dr. Bawa is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm founded in 2002 and based in Ashburn, VA. He is an inventor, entrepreneur, professor and registered patent agent licensed to practice before the U.S. Patent & Trademark Office. Trained as a biochemist and microbiologist, he has extensive expertise in nanotechnology, pharmaceutical sciences, biotechnology, drug delivery and biodefense-related scientific, FDA regulatory and patent law issues. He is currently an adjunct professor of biological sciences at Rensselaer Polytechnic Institute (Troy, NY), the university where he obtained his doctoral degree in three years (biophysics/biochemistry). Dr. Bawa is a scientific advisor to Teva Pharmaceutical Industries (Israel) and has served as a principal investigator of National Cancer Institute SBIRs and reviewer for both the National Institutes of Health and the National Science Foundation. He has authored over 100 publications, coedited three books, presented or chaired at over 200 conferences worldwide and serves on the editorial boards of 10 peer-reviewed journals.
Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: jmorbit@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.